C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 01 2019
Historique:
received: 11 06 2018
accepted: 19 12 2018
entrez: 22 1 2019
pubmed: 22 1 2019
medline: 6 2 2019
Statut: epublish

Résumé

Single-cell transcriptomic profiling is a powerful tool to explore cellular heterogeneity. However, most of these methods focus on the 3'-end of polyadenylated transcripts and provide only a partial view of the transcriptome. We introduce C1 CAGE, a method for the detection of transcript 5'-ends with an original sample multiplexing strategy in the C1

Identifiants

pubmed: 30664627
doi: 10.1038/s41467-018-08126-5
pii: 10.1038/s41467-018-08126-5
pmc: PMC6341120
doi:

Substances chimiques

RNA, Messenger 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

360

Références

FEBS Lett. 2012 Jul 4;586(14):1959-70
pubmed: 22710176
RNA Biol. 2017 May 4;14(5):637-650
pubmed: 27442339
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
Nature. 2017 Mar 9;543(7644):199-204
pubmed: 28241135
Nucleic Acids Res. 2017 Apr 7;45(6):3017-3030
pubmed: 27932455
Nucleic Acids Res. 2013 Feb 1;41(3):e44
pubmed: 23180801
Biochem J. 2009 Apr 15;419(2):485-95
pubmed: 19076057
Nature. 2014 Mar 27;507(7493):462-70
pubmed: 24670764
Science. 2015 Apr 24;348(6233):aaa6090
pubmed: 25858977
Trends Biochem Sci. 2014 Apr;39(4):170-82
pubmed: 24674738
Nat Rev Cancer. 2010 Jun;10(6):415-24
pubmed: 20495575
Science. 1998 Apr 24;280(5363):585-90
pubmed: 9554849
Sci Rep. 2017 Jan 03;7:39921
pubmed: 28045081
Nat Methods. 2014 Jan;11(1):41-6
pubmed: 24141493
Nature. 2014 Mar 27;507(7493):455-461
pubmed: 24670763
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nat Commun. 2018 Feb 12;9(1):619
pubmed: 29434199
Science. 2015 Feb 27;347(6225):1010-4
pubmed: 25678556
Nat Rev Cancer. 2013 Aug;13(8):585-95
pubmed: 23842645
Nat Rev Genet. 2016 Apr;17(4):207-23
pubmed: 26948815
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nucleic Acids Res. 2018 Jan 4;46(D1):D781-D787
pubmed: 29045713
Nat Methods. 2017 May;14(5):483-486
pubmed: 28346451
Nat Methods. 2008 Oct;5(10):877-9
pubmed: 18806792
Nat Biotechnol. 2016 Nov 8;34(11):1145-1160
pubmed: 27824854
Genome Res. 2015 Oct;25(10):1491-8
pubmed: 26430159
J Immunol Methods. 1993 Aug 9;163(2):181-5
pubmed: 8354887
Genome Biol. 2010;11(2):R14
pubmed: 20132535
Nat Methods. 2010 Jul;7(7):528-34
pubmed: 20543846
EMBO J. 2009 Nov 18;28(22):3591-601
pubmed: 19798054
Nat Biotechnol. 2014 Mar;32(3):217-9
pubmed: 24727769
Nat Methods. 2015 Oct;12(10):947-950
pubmed: 26301841
Mol Cell. 2013 Sep 12;51(5):606-17
pubmed: 23993744
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1433-8
pubmed: 19164764
Nucleic Acids Res. 2016 Jan 4;44(D1):D110-5
pubmed: 26531826
Bioinformatics. 2016 Sep 15;32(18):2858-60
pubmed: 27334471
Nat Genet. 2006 Jun;38(6):626-35
pubmed: 16645617
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell. 2008 Jul 25;134(2):215-30
pubmed: 18662538
Nucleic Acids Res. 2016 Jul 27;44(13):e117
pubmed: 27179027
Science. 2011 Apr 22;332(6028):472-4
pubmed: 21415320
BMC Bioinformatics. 2015 Jan 28;16:24
pubmed: 25627334
Methods Mol Biol. 2014;1164:67-85
pubmed: 24927836
Nat Methods. 2017 Apr;14(4):381-387
pubmed: 28263961
Nucleic Acids Res. 2018 Jan 4;46(D1):D267-D275
pubmed: 29126285
F1000Res. 2016 Aug 31;5:2122
pubmed: 27909575
Mol Cell Biol. 2012 May;32(9):1633-44
pubmed: 22371483
Biotechniques. 2016 Apr 01;60(4):169-74
pubmed: 27071605
Trends Cell Biol. 2013 Dec;23(12):603-11
pubmed: 23838335
Methods. 2015 Sep 1;85:54-61
pubmed: 26142758
Genome Biol. 2016 Apr 27;17:75
pubmed: 27122128
Mol Cancer. 2008 Nov 24;7:87
pubmed: 19025616
Nat Commun. 2014 Sep 25;5:5125
pubmed: 25254650
Mol Cell. 2015 Apr 2;58(1):147-56
pubmed: 25728770
Methods Mol Biol. 2017;1543:57-109
pubmed: 28349422
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Methods Mol Biol. 2017;1468:19-32
pubmed: 27662867
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15776-81
pubmed: 14663149
Oncogene. 2015 Jan 22;34(4):436-44
pubmed: 24469049
Oncogene. 1999 Jan 7;18(1):269-75
pubmed: 9926943
Nat Methods. 2014 Feb;11(2):163-6
pubmed: 24363023
Nucleic Acids Res. 2012 Sep 1;40(17):e133
pubmed: 22638577
Biochim Biophys Acta. 2011 Dec;1813(12):2099-107
pubmed: 21839117

Auteurs

Tsukasa Kouno (T)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Jonathan Moody (J)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Andrew Tae-Jun Kwon (AT)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Youtaro Shibayama (Y)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Sachi Kato (S)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Yi Huang (Y)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
ACT Genomics Co. Ltd., 3F., No. 345, Xinhu 2nd Rd, Neihu Dist., Taipei City, 114, Taiwan.

Michael Böttcher (M)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Efthymios Motakis (E)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Yong Loo Lin School of Medicine MD6, #08-01, 14 Medical Drive, National University of Singapore, Singapore, 117599, Singapore.

Mickaël Mendez (M)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Princess Margaret Cancer Research Tower 11-401, 101 College Street, Toronto, ON, M5G 1L7, Canada.

Jessica Severin (J)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Joachim Luginbühl (J)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Imad Abugessaisa (I)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Akira Hasegawa (A)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Satoshi Takizawa (S)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Takahiro Arakawa (T)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Masaaki Furuno (M)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Naveen Ramalingam (N)

Single-Cell Research and Development, Fluidigm Corporation, 7000 Shoreline Court, Suite 100, South San Francisco, 94080, CA, USA.

Jay West (J)

Single-Cell Research and Development, Fluidigm Corporation, 7000 Shoreline Court, Suite 100, South San Francisco, 94080, CA, USA.

Harukazu Suzuki (H)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Takeya Kasukawa (T)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Timo Lassmann (T)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Telethon Kids Institute, The University of Western Australia, Perth Children's Hospital, 15 Hospital Ave, Nedlands, 6009, WA, Australia.

Chung-Chau Hon (CC)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Erik Arner (E)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Piero Carninci (P)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Charles Plessy (C)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. charles.plessy@oist.jp.
Okinawa Institute of Science and Technology Graduate University (OIST), 1919-1 Tancha, Onna-son, Kunigami-gun, Okinawa, 904-0495, Japan. charles.plessy@oist.jp.

Jay W Shin (JW)

RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. jay.shin@riken.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH